BIRC2 and glioblastoma: BIRC2 is highly expressed in various tumours, including breast cancer, melanoma, glioblastoma, gallbladder cancer and nasopharyngeal carcinoma, and plays a crucial role in the escape of tumour cells from apoptosis [51–54].